Managing geriatric arrhythmias, II: Drug selection and use

Area of Science:

• Pharmacology
• Geriatrics
• Clinical Pharmacy

Background:

• Aging alters drug pharmacokinetics, increasing adverse event risk in elderly patients.
• Antiarrhythmic drugs require careful management due to potential toxicity and interactions.
• Geriatric population exhibits unique physiological changes affecting drug disposition.

Purpose of the Study:

• To review the pharmacology, indications, and adverse effects of antiarrhythmic agents.
• To provide dosing guidelines for antiarrhythmic drugs in geriatric patients.
• To highlight strategies for minimizing risks associated with antiarrhythmic drug use in the elderly.

Main Methods:

• Review of current antiarrhythmic pharmacology and clinical use.
• Analysis of age-related pharmacokinetic changes impacting drug distribution, metabolism, and excretion.
• Guideline development for geriatric dosing and therapeutic drug monitoring.

Main Results:

• Age-related changes can lead to antiarrhythmic drug accumulation and increased adverse drug reactions.
• Modest initial dosages with slow titration effectively minimize risks.
• Therapeutic drug monitoring aids in optimizing dosing regimens for elderly patients.

Conclusions:

• Optimized antiarrhythmic drug therapy in the elderly requires consideration of age-specific pharmacokinetic alterations.
• Judicious dosing strategies and therapeutic drug monitoring are essential for patient safety.
• This review provides practical guidance for managing antiarrhythmic medications in geriatric individuals.